Results for tag: "Moxisylyte"

Moxisylyte is a cardiovascular drug used to treat peripheral vascular diseases, such as Raynaud's phenomenon, chronic venous insufficiency, and arterial occlusive diseases. It is a vasodilator, meaning it relaxes the walls of blood vessels, allowing them to widen and increase blood flow. It is available in both oral and injectable forms, and is often used in combination with other drugs to treat more severe cases. Moxisylyte is a relatively new drug, and is still in the early stages of development. It is not yet widely available, but is gaining traction in the market due to its potential to treat a variety of cardiovascular diseases. Some companies in the Moxisylyte market include Sanofi, Pfizer, Novartis, and Merck. Show Less Read more